Stallergenes Greer gets positive EMA committee opinion for extension of indication of Palforzia to treat toddlers with confirmed peanut allergy: Baar, Switzerland Tuesday, Decembe ...
BioNxt Solutions announces development of sublingual thin-film ODF for Semaglutide: Vancouver, BC Tuesday, December 3, 2024, 17:00 Hrs [IST] BioNxt Solutions Inc., a bioscience co ...
US FDA grants Orphan Drug Designation to AAVantgarde Bio’s AAVB-081 to treat Usher Syndrome Type 1B retinitis pigmentosa: Milan, Italy Tuesday, December 3, 2024, 16:00 Hrs [IST] ...
Endo introduces US FDA approved Adrenalin ready-to-use premixed bag: Malvern, Pennsylvania Tuesday, December 3, 2024, 15:00 Hrs [IST] Endo, Inc., a diversified specialty pharmaceu ...
PTC Therapeutics inks global license and collaboration agreement with Novartis for PTC518 Huntington's disease programme: Warren, New Jersey Tuesday, December 3, 2024, 14:00 Hrs [ ...
“Indian Pharma MSMEs are now more proactive in implementing the Revised Schedule M guidelines. They are gearing up to establish a robust Pharmaceutical Quality System (PQS), integrate Quality Risk ...
Bayer showcases innovations in radiology portfolio at RSNA 2024 meeting: Berlin Tuesday, December 3, 2024, 13:00 Hrs [IST] Bayer continues to advance its comprehensive radiology p ...
HCG and Accenture collaborate on cancer research and care using advanced AI: Our Bureau, Bengaluru Tuesday, December 3, 2024, 12:50 Hrs [IST] HealthCare Global Enterprises (HCG) i ...
Our Bureau, Bengaluru Tuesday, December 3, 2024, 12:40 Hrs [IST] Gland Pharma, a generic injectable–focused pharmaceut ...
Neo Medical’s spine care platform fully approved under EU Medical Device Regulation directive: Lausanne, Switzerland Tuesday, December 3, 2024, 12:00 Hrs [IST] Neo Medical SA (N ...
Renalys Pharma’s sparsentan receives Japanese Orphan Drug Designation for primary IgA nephropathy: Tokyo, Japan Tuesday, December 3, 2024, 11:00 Hrs [IST] Renalys Pharma, Inc., ...
Everest Medicines announces acceptance of Velsipity NDA in Hong Kong to treat moderately to severely active ulcerative colitis: Shanghai, China Tuesday, December 3, 2024, 10:00 Hr ...